inVentiv Health to Present at UBS Warburg Global Life Sciences Conference

SOMERSET, N.J., Sept. 17 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. today announced that Eran Broshy, Chairman and Chief Executive Officer and David Bassin, Chief Financial Officer will make a presentation at the UBS Global Life Sciences conference taking place September 24 - 27 at The Grand Hyatt in New York.

inVentiv Health's presentation will take place on Wednesday, September 26 at 10:00 a.m. An audio webcast of the presentation can be accessed by logging on to www.inventivhealth.com/health/newsroom/webcasts.asp.

About inVentiv Health

inVentiv Health is the leading provider of commercialization and complementary services to the healthcare industry globally. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 250 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.

CONTACT: Investors-Corporate: David Bassin, CFO, +1-732-537-4804,investor@inventivhealth.com, or Media: Marcia Frederick, +1-614-543-6281,mfrederick@inventivhealth.com, both of inVentiv Health, Inc.

Web site: http://www.inventivhealth.com/